Xhemalce received her Ph.D. at the Pasteur Institute in Paris, France and performed her postdoctoral training at the Gurdon Institute at the University of Cambridge in the United Kingdom. The focus of her research is to unravel how gene expression is regulated by epigenetic modifications of chromatin and RNAs. The ultimate goal of her lab is to discover novel enzymes, writers, or erasers of such modifications that are potential targets for therapeutic drugs that could alleviate human diseases including cancer. To achieve this goal the Xhemalce lab uses a diverse array of approaches, including cellular and molecular biology, biochemistry, and mass spectrometry. The Xhemalce lab is also committed to supporting its members to achieve their academic goals and to think outside the box.
